Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Rubio-Guerra S, Sala I, Sánchez-Saudinós MB, Videla L, Bejanin A, Estanga A, Ecay-Torres M, de Luis CL, Rami L, Tort-Merino A, Castellví M, Pozueta A, García-Martínez M, Gómez-Andrés D, Lage C, López-García S, Sánchez-Juan P, Balasa M, Lladó A, Altuna M, Tainta M, Arranz J, Zhu N, Alcolea D, Lleó A, Fortea J, Rodríguez ER, Sánchez-Valle R, Martínez-Lage P, Illán-Gala I

Open source

DOI: 10.1002/dad2.70223
Published: 2025 Oct-Dec
Container: Alzheimer's & dementia (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/dad2.70223,
  title = {Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.},
  author = {Rubio-Guerra S and Sala I and Sánchez-Saudinós MB and Videla L and Bejanin A and Estanga A and Ecay-Torres M and de Luis CL and Rami L and Tort-Merino A and Castellví M and Pozueta A and García-Martínez M and Gómez-Andrés D and Lage C and López-García S and Sánchez-Juan P and Balasa M and Lladó A and Altuna M and Tainta M and Arranz J and Zhu N and Alcolea D and Lleó A and Fortea J and Rodríguez ER and Sánchez-Valle R and Martínez-Lage P and Illán-Gala I},
  year = {2025},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  doi = {10.1002/dad2.70223},
  url = {https://doi.org/10.1002/dad2.70223}
}

RIS

TY  - JOUR
TI  - Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.
AU  - Rubio-Guerra S
AU  - Sala I
AU  - Sánchez-Saudinós MB
AU  - Videla L
AU  - Bejanin A
AU  - Estanga A
AU  - Ecay-Torres M
AU  - de Luis CL
AU  - Rami L
AU  - Tort-Merino A
AU  - Castellví M
AU  - Pozueta A
AU  - García-Martínez M
AU  - Gómez-Andrés D
AU  - Lage C
AU  - López-García S
AU  - Sánchez-Juan P
AU  - Balasa M
AU  - Lladó A
AU  - Altuna M
AU  - Tainta M
AU  - Arranz J
AU  - Zhu N
AU  - Alcolea D
AU  - Lleó A
AU  - Fortea J
AU  - Rodríguez ER
AU  - Sánchez-Valle R
AU  - Martínez-Lage P
AU  - Illán-Gala I
PY  - 2025
JO  - Alzheimer's & dementia (Amsterdam, Netherlands)
DO  - 10.1002/dad2.70223
UR  - https://doi.org/10.1002/dad2.70223
ER  -

APA

S, R., I, S., MB, S., L, V., A, B., A, E., M, E., CL, D. L., L, R., A, T., M, C., A, P., M, G., D, G., C, L., S, L., P, S., M, B., A, L., M, A., M, T., J, A., N, Z., D, A., A, L., J, F., ER, R., R, S., P, M., & I, I. (2025). Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.. Alzheimer's & dementia (Amsterdam, Netherlands). https://doi.org/10.1002/dad2.70223

Source records

pubmed · retrieved 2026-09-27T01:56:23.842Z